WCM
SLXN

Wildcat Capital Management’s Silexion Therapeutics Corp Ordinary Shares SLXN Stock Holding History

Wildcat Capital Management’s Portfolio SLXN Stock Details SLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$91.9K Hold
7,562
– – 0.05% 6
2025
Q1 		$125K Hold
7,562
– – 0.07% 8
2024
Q4 		$228K Hold
7,562
– – 0.09% 8
2024
Q3 		$536K Buy
+7,562
New +$536K 0.26% 7